Aadi Bioscience, Inc.
Aadi Bioscience, Inc.（AADI）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AADI · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
15
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Aadi Bioscience, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
AADI 季度内部人买卖趋势
AADI 内幕交易卖出 · AADI 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
AADI 高管卖出股份 · AADI 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 4, 2025 | Dalal Anupam Director | Award | 1,561,000 | $3.75M⚡ | Form 4 |
| Mar 4, 2025 | Castelein Caley Director | Award | 1,666,000 | $4.00M⚡ | Form 4 |
| Mar 4, 2025 | Zhao Baiteng Director | Award | 1,250,000 | $3.00M⚡ | Form 4 |
| Mar 4, 2025 | BALL BRYAN See remarks | Award | 100,000 | $240K | Form 4 |
| Mar 1, 2025 | BALL BRYAN See remarks | Option | 5,000 | — | Form 4 |
| Mar 3, 2025 | BALL BRYAN See remarks | Sale | 2,147 | $5K | Form 4 |
| Mar 1, 2025 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Option | 6,750 | — | Form 4 |
| Mar 3, 2025 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Sale | 2,806 | $7K | Form 4 |
| Mar 1, 2025 | Lennon David James CHIEF EXECUTIVE OFFICER · Director | Option | 16,250 | — | Form 4 |
| Mar 3, 2025 | Lennon David James CHIEF EXECUTIVE OFFICER · Director | Sale | 5,690 | $13K | Form 4 |
| Oct 2, 2024 | Lennon David James CHIEF EXECUTIVE OFFICER · Director | Option | 32,558 | — | Form 4 |
| Oct 3, 2024 | Lennon David James CHIEF EXECUTIVE OFFICER · Director | Sale | 9,689 | $19K | Form 4 |
| Sep 3, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 40,000 | $68K | Form 4 |
| Aug 1, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 15,415 | $23K | Form 4 |
| Aug 2, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 18,933 | $27K | Form 4 |
| Aug 5, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 5,652 | $8K | Form 4 |
| Jul 1, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 31,348 | $46K | Form 4 |
| Jul 2, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 8,652 | $12K | Form 4 |
| Jun 3, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 19,775 | $36K | Form 4 |
| Jun 4, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 20,225 | $36K | Form 4 |
| May 1, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 40,000 | $77K | Form 4 |
| Apr 1, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 17,772 | $41K | Form 4 |
| Apr 2, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 22,228 | $50K | Form 4 |
| Mar 1, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 27,036 | $53K | Form 4 |
| Mar 4, 2024 | Desai Neil EXECUTIVE CHAIRMAN · Director | Sale | 14,964 | $31K | Form 4 |
Lennon David James
CHIEF EXECUTIVE OFFICER · Director
日期
Mar 1
股数
16,250
均价
—
总金额
—
Lennon David James
CHIEF EXECUTIVE OFFICER · Director
日期
Mar 3
股数
5,690
均价
$2.35
总金额
$13K
Lennon David James
CHIEF EXECUTIVE OFFICER · Director
日期
Oct 2
股数
32,558
均价
—
总金额
—
Lennon David James
CHIEF EXECUTIVE OFFICER · Director
日期
Oct 3
股数
9,689
均价
$1.94
总金额
$19K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AADI 内幕交易
AADI 内幕交易
Aadi Bioscience, Inc.（AADI）内幕交易数据来源于公司内部人（包括AADI）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。AADI内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Aadi Bioscience, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AADI 内幕交易 · 5个问题Aadi Bioscience, Inc.（AADI）的内部人包括高管和董事，如AADI等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026